New Key Statistics Module, Z-Score and F-Score
SZSE:301281 Key Ratios
Market Cap ¥ M | 2,320.66 |
Enterprise Value ¥ M | 2,386.53 |
P/E(ttm) | 35.96 |
PE Ratio without NRI | 22.28 |
Forward PE Ratio | -- |
Price/Book | 1.72 |
Price/Sales | 5.11 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | 18.76 |
Payout Ratio % | 0.42 |
Revenue (TTM) ¥ M | 469.00 |
EPS (TTM) ¥ | 0.60 |
Beneish M-Score | 0.4 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | 10.70 |
y-y EBITDA Growth Rate % | -66.80 |
EV-to-EBIT | 44.15 |
EV-to-EBITDA | 44.15 |
PEG | 2.08 |
Shares Outstanding M | 108.29 |
Net Margin (%) | 14.16 |
Operating Margin % | 11.51 |
Pre-tax Margin (%) | 14.34 |
Quick Ratio | 5.83 |
Current Ratio | 6.62 |
ROA % (ttm) | 4.55 |
ROE % (ttm) | 5.02 |
ROIC % (ttm) | 7.54 |
Dividend Yield % | 1.39 |
Altman Z-Score | 10.75 |
SZSE:301281 Number of Guru Trades
SZSE:301281 Volume of Guru Trades
Gurus Latest Trades with SZSE:301281
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:301281 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Shandong Keyuan Pharmaceutical Co Ltd Insider Transactions
No Available Data